Author: sugaradmin

Introduction and Objective: Despite GLP1ra or SGLT2i therapy, many adults with insulin treated type 2 diabetes (T2D) remain above HbA1c targets. AID may provide benefit for T2D. The study objective was to evaluate efficacy and safety of the twiist AID system, which uses the novel twiist pump and Tidepool Loop algorithm, in adults with insulin-treated […]

Introduction and Objective: Virtual environments may enhance social support through interactive and immersive engagement; however, evidence of their long-term impact remains limited. This study aims to examine the effect of a 3D virtual diabetes self-management education and support (DSME/S) intervention (Learning in a Virtual Environment [LIVE]) on perceived social support and its association with behavioral […]

Introduction and Objective: Type 1 diabetes (T1D) leads to vascular complications including chronic kidney disease (CKD) and major adverse cardiovascular events (MACE). Patients with T1D are at high risk for developing CKD, but contemporary data on the natural history of kidney function decline and the effect of therapies on slowing eGFR decline in T1D-related CKD […]

Introduction and Objective: Hypercortisolism is present in almost 1 in 4 patients with difficult-to-control type 2 diabetes (T2D) per the CATALYST study, yet often goes undetected as current diagnostics rely on single-timepoint assessments. These patients undergo escalation of medication for glycemic control without assessing underlying metabolic contributors. Continuous cortisol monitoring (CCM), analogous to continuous glucose […]

Introduction and Objective: While high-dose metformin use often signals advanced disease, the clinical relevance of dose-associated proteomic profile remains unclear. We aimed to identify a dose-dependent proteomic profile and associations with clinical traits and cardiometabolic events.Methods: In a discovery cohort of 1,246 Koreans with type 2 diabetes and eGFR >30 mL/min/1.73 m², we analyzed 5,416 […]

Introduction and Objective: Obesity is a major risk factor for metabolic dysfunction-associated steatotic liver disease (MASLD), yet it is metabolically heterogeneous. The impact of distinct metabolic states on MASLD risk across varying degrees of obesity remains unclear. We aimed to evaluate the associations between metabolic obesity phenotypes and liver fibrosis in MASLD.Methods: Two cross-sectional cohorts […]

Introduction and Objective: Negative comments on body image and visible weight loss from friends, family, and peers may influence treatment discontinuation. This study evaluated societal influences reported treatment discontinuation with GLP along with weight regain.Methods: This observational study included adults on GLP-1-based therapy for weight loss with a minimum follow-up of 1 year. Weight loss […]

Introduction and Objective: Glycemic fluctuations across the menstrual cycle have been reported in women with type 1 diabetes (T1D), yet evidence in Asian populations remains limited. This study aimed to explore phase-related differences in glucose profiles across the menstrual cycle in Chinese women with T1D using continuous glucose monitoring (CGM), with an additional exploratory case […]

Introduction and Objective: Health inequities continue to drive disparities in diabetes outcomes across the United States. To help identify barriers to facilitators of health equity improvement, the T1D Exchange QI Collaborative conducted an assessment of member centers.Methods: The annual T1DX-QI survey was administered via Qualtrics from August to October 2025 to collect data from 2023. […]

Introduction and Objective: Gastrointestinal tolerability is a key consideration for weight loss therapies targeting appetite-regulating pathways. Conditioned taste avoidance (CTA) in rodents is a widely used preclinical model to evaluate the potential of compounds to produce nausea and gastrointestinal discomfort. We compared food intake inhibition and CTA responses induced by a small molecule amylin receptor […]